Clinical Evidence Tirzepatide Weight Loss: SURMOUNT-1 Trial Data Tirzepatide produces the highest mean weight loss of any GLP-1 medication
A person with a BMI of 28 and a history of gestational diabetes may benefit from one of these medications to lose weight while concomitantly mastering lifestyle behaviors, and then transition off the weight management medications to lifestyle alone, says Linda Gigliotti, MS, RDN, CDCES, CSOWM, an obesity and weight management specialist based in Irvine, California
Summary Diabetes doesnt only deplete GSH it impairs enzymes in the glutathione system (like glutathione synthetase, -glutamylcysteine synthetase, glutathione peroxidase)
The majority of Americans are obese or overweight, a problem that puts their health and emotional well-being at risk
However, a 2024 study involving over 2,000 participants found that gradually tapering the dose , rather than stopping suddenly, helped many individuals maintain their weight loss